The manufacturing success in China has not yet radiated to the pharmaceutical sector. Recently, China released a policy guideline to foster its follow-on drug industry, revealing its ambition to become a great power in the field. Here, I briefly discuss how this guideline may change the industry landscape, and its associated challenges and opportunities.
Date:
2018-10
Relation:
Trends in Pharmacological Sciences. 2018 Oct;39(10):843-848.
